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Behorende bij het proefschrift 
Adjuvanted nanoparticulate seasonal influenza vaccines 
1. There is a need for research in new adjuvanted influenza vaccines, as the current vaccines lack 
efficacy and immunogenicity in some populations. 
Chapter 1 
2. Polymersomes composed of block copolymers, with amphiphilic properties similar to lipids but having 
much larger molecular weights, somehow resemble viral capsids composed of large polypeptide 
chains. 
Chapter 3 
3. Conjugation of a peptide to a hydrophobic anchor strongly affects the supramolecular assembly of 
peptide-based nanoparticles. 
Chapter4 
4. The adjuvant effect of cationic liposomes not only depends on their charge, but also on the cationic 
compound selected and its amount in the liposomal bilayer. 
Chapter 6 
5. There is growing evidence that both (C04+) T helper cells and (COS+) cytotoxic T lymphocytes not only 
play an important role in controlling viral infection, but also may reduce the severity of disease and 
decrease mortality. The use of cationic liposomes containing immune modulators such as CpG to 
increase the immunogenicity of the antigen and modulate the immune response towards the Thl 
direction is therefore a highly relevant approach. 
Chapter 6 
6. Polymersomes can be tuned to specific sizes for particular routes of administration, improved 
mechanical stability, and stimuli responsiveness, and can be functionalized for targeting approaches. 
Tanner P et al., Ace Chem Res, 2011 
7. Adjuvants are necessary to improve the immune responses to highly purified and well-defined 
antigens. lt is our contention that we need to create adjuvant formulations of these antigens, which 
are equally well characterized and defined as the antigens. 
Brlto, LA. et at, Semin lmmunol, 2013 
S. Cationic liposomes are a valuable tool for augmenting the effect of immunomodulators. This has 
particularly been investigated with agonists for TLRs. By targeting these receptors, it is possible to 
design adjuvants that selectively stimulate a distinct immunological profile, such as the COST-cell. 
Christensen, D. et al., Expert Rev Vaccines, 2007 
9. Biophysical formulation parameters are important determinants of antigen specific immune 
responses elicited by liposomal vaccines, even in the presence of potent immunostimulants. 
Watron, 0 S, Vaccine, 2012 
10. The scientist is not a person who gives the right answers, he's one who asks the right questions. 
Claude Levi-Strauss 
